The contract research organization is cutting jobs at its Wilmington headquarters as it undergoes a shakeup led by a new ...
This collaboration supports the advancement of the EpiCapture test, which is currently in late-stage development, to regulatory approval and commercialization. This initiative is part of Trinity ...
Initiated development of a second CAPTN-3 tri-specific antibody targeting TROP2 Manufacturing milestone achieved for IM1240, the first ...
Research and development expenses were $13.7 million for the three months ended September 30, 2025, compared to $20.2 million for the three months ended September 30, 2024. The company recognized $0.6 ...
PDS Biotechnology Corporation (NASDAQ: PDSB) Q3 2025 Earnings Call Transcript November 13, 2025 ...
A company focused on cancer and inflammatory disease therapies has opened a new research laboratory in Charlotte.
Just months after KBio Inc. announced it would permanently close its Owensboro facility and eliminate 46 jobs, a group of ...
What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?
Medical Device Network on MSN
Estonia’s digital health DNA: Trust, data, and biotech in focus
From e-health records to a biotech hub in Tartu, Estonia is harnessing data, digital infrastructure, and investment to drive ...
Dr. Richard Pazdur is “likely the best possible person for the role,” says one analyst. A calmer course for the FDA could add ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results